In both datasets, MVP, GRN, and ERP29 showed significantly higher expression levels, while RNF128, NFYB, and KPNA3 had significantly lower expression levels in dysferlinopathy than normal controls (Figures 5A,B). Here, NFYB is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.